In 2006, the Federal Food, Drug and Cosmetic Act gave the FDA the power to require manufacturers to conduct postmarket surveillance for certain type of devices. Now, a decade later, the FDA has released guidance for these manufacturers.

When colorectal cancer comes back after initial surgical intervention, chances are it won’t be detected until troubling symptoms prompt the patient to make an unscheduled interval visit. 

Researchers from Mount Sinai’s Icahn School of Medicine are using cutting-edge ligands to examine the brains of NFL and NHL players who are at-risk for brain damage, the New York Daily News reports. 

Stanford biologists and engineers are working with gold nanoparticles to identify tumor margins practically down to the level of the individual cell.

A recent post on Scout.com’s Mile High Huddle page examined the topic of traumatic brain injuries (TBIs) in the NFL by detailing research of blast-related injuries suffered by members of the U.S. Military. 

PACS technology has worked wonders improving efficiency in radiology, but it’s doing a number on radiologists’ relationships with people whose work falls within, or reaches into, the imaging circle. 

A newly developed PET tracer has shown that tau protein clumps within the brain are better indicators of cognitive impairment related to Alzheimer’s disease than beta amyloid proteins, the current standard for evaluating the disease’s progress, according to results of a new study recently published in the journal Science Translational Medicine.

Researchers from Washington University in St. Louis have used an innovative imaging technique to reveal that a protein in the brain known as tau is suggestive of a patient’s cognitive function, according to results of a study recently published in Science Translational Medicine.